about
The evolution of tafenoquine--antimalarial for a new millennium?Antimalarial drug resistance: An overviewPediatric imported malaria in New York: delayed diagnosis.Distinct patterns of diversity, population structure and evolution in the AMA1 genes of sympatric Plasmodium falciparum and Plasmodium vivax populations of Papua New Guinea from an area of similarly high transmissionIn silico studies on DARC.Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.Research challenges and gaps in malaria knowledge in Papua New Guinea.Chloroquine resistance in Plasmodium vivax.Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.Malaria vaccine development.Sequence analysis of pfcrt and pfmdr1 genes and its association with chloroquine resistance in Southeast Indian Plasmodium falciparum isolates.Management of relapsing Plasmodium vivax malariaThe pharmacokinetics of chloroquine in healthy Thai subjects and patients with Plasmodium vivax malaria.Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.[Assessment of the response to reduced treatment schemes for vivax malaria].Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of the Amazon region of Brazil and their correlation with chloroquine treatment.Chloroquine-resistant Plasmodium vivax in Papua New Guinea.Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys
P2860
Q24536171-678C44A6-BAEC-42C4-8E23-05B2A89181CEQ26753085-3B1280B5-5309-4256-9A1C-B58216F39FCDQ33329267-1463C1BA-5056-46F0-9301-E4D95B2CB062Q33859217-7F34070D-EE74-453A-828B-A325EC856CE8Q34658695-7202CE93-CD32-480E-84DF-7498FE0F9CF5Q34660024-80EC7825-FEBF-426C-BCF1-38A31D9B9FABQ35649165-82F3B479-91A8-45A8-98CA-1CAAE801B0E1Q35927662-1E65C886-CBF6-4377-A94A-A239821BE9A6Q36592120-CD97BC80-7AE3-4211-BD80-06AC1196FA66Q36634918-79E9A600-BDB0-41A1-85A5-2BB18E20A2CDQ36641624-C407F7CA-E4FC-4DB1-A09B-85E816962DCBQ36870082-F30174A3-7CC1-4237-ACED-7991078483BBQ37290599-A3A230F8-2074-4C00-AAD6-B6345AC97883Q39288487-BBD8D884-49BC-45E8-A078-E34D791F4AA6Q39293411-C2B3E52F-EF0B-46DD-AC28-0C12D966F840Q40485571-3EEA1854-829B-40C2-9B5E-19943BFB9D91Q41918855-28DED851-D280-451F-A18A-633AA9EDEB4BQ41920647-7063289C-E68C-45B5-AF23-56DA31DAE018Q41940524-21924C4B-663F-497A-8EA6-A5F527DB4F83Q41943311-4BCEEF32-5FC9-4ED1-BF24-DF1C319584AAQ56339945-06C9DD52-CFDF-444F-A82A-1F88EAAEB3F1
P2860
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Chloroquine-resistant Plasmodium vivax.
@en
Chloroquine-resistant Plasmodium vivax.
@nl
type
label
Chloroquine-resistant Plasmodium vivax.
@en
Chloroquine-resistant Plasmodium vivax.
@nl
prefLabel
Chloroquine-resistant Plasmodium vivax.
@en
Chloroquine-resistant Plasmodium vivax.
@nl
P2093
P1433
P1476
Chloroquine-resistant Plasmodium vivax.
@en
P2093
J R Veenendaal
K Rieckmann
P356
10.1016/S0140-6736(89)92002-3
P407
P577
1989-12-01T00:00:00Z